187 related articles for article (PubMed ID: 17408594)
1. Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2.
Kim SR; Bae SK; Choi KS; Park SY; Jun HO; Lee JY; Jang HO; Yun I; Yoon KH; Kim YJ; Yoo MA; Kim KW; Bae MK
Biochem Biophys Res Commun; 2007 May; 357(1):150-6. PubMed ID: 17408594
[TBL] [Abstract][Full Text] [Related]
2. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis.
Bae YH; Bae MK; Kim SR; Lee JH; Wee HJ; Bae SK
Biochem Biophys Res Commun; 2009 Feb; 379(2):206-11. PubMed ID: 19100714
[TBL] [Abstract][Full Text] [Related]
4. Neuromedin B induces angiogenesis via activation of ERK and Akt in endothelial cells.
Park HJ; Kim SR; Bae SK; Choi YK; Bae YH; Kim EC; Kim WJ; Jang HO; Yun I; Kim YM; Bae MK
Exp Cell Res; 2009 Nov; 315(19):3359-69. PubMed ID: 19703440
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic role of orexin-A via the activation of extracellular signal-regulated kinase in endothelial cells.
Kim MK; Park HJ; Kim SR; Choi YK; Shin HK; Jeon JH; Jang HO; Yun I; Bae SK; Bae MK
Biochem Biophys Res Commun; 2010 Dec; 403(1):59-65. PubMed ID: 21040705
[TBL] [Abstract][Full Text] [Related]
6. Visfatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells.
Liu SW; Qiao SB; Yuan JS; Liu DQ
Horm Metab Res; 2009 Apr; 41(4):281-6. PubMed ID: 19009499
[TBL] [Abstract][Full Text] [Related]
7. Involvement of dimethylarginine dimethylaminohydrolase-2 in visfatin-enhanced angiogenic function of endothelial cells.
Xiao J; Xiao ZJ; Liu ZG; Gong HY; Yuan Q; Wang S; Li YJ; Jiang DJ
Diabetes Metab Res Rev; 2009 Mar; 25(3):242-9. PubMed ID: 19229883
[TBL] [Abstract][Full Text] [Related]
8. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
9. The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway.
Pyriochou A; Zhou Z; Koika V; Petrou C; Cordopatis P; Sessa WC; Papapetropoulos A
J Cell Physiol; 2007 Apr; 211(1):197-204. PubMed ID: 17226792
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a benzoxazine derivative promoting angiogenesis in vitro and in vivo.
Dong Z; Cheng Y; Zhao J; Su L; Zhao B; Zhang Y; Zhang S; Miao J
J Cell Physiol; 2010 Apr; 223(1):202-8. PubMed ID: 20049873
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
12. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide.
Wang P; Xu TY; Guan YF; Su DF; Fan GR; Miao CY
Cardiovasc Res; 2009 Feb; 81(2):370-80. PubMed ID: 18952695
[TBL] [Abstract][Full Text] [Related]
13. Evidence of human thrombomodulin domain as a novel angiogenic factor.
Shi CS; Shi GY; Chang YS; Han HS; Kuo CH; Liu C; Huang HC; Chang YJ; Chen PS; Wu HL
Circulation; 2005 Apr; 111(13):1627-36. PubMed ID: 15795324
[TBL] [Abstract][Full Text] [Related]
14. Okadaic acid promotes angiogenesis via activation of hypoxia-inducible factor-1.
Kim YS; Ahn KH; Kim SY; Jeong JW
Cancer Lett; 2009 Apr; 276(1):102-8. PubMed ID: 19054610
[TBL] [Abstract][Full Text] [Related]
15. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
16. Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway.
Park JW; Kim WH; Shin SH; Kim JY; Yun MR; Park KJ; Park HY
Biochim Biophys Acta; 2011 May; 1813(5):763-71. PubMed ID: 21329734
[TBL] [Abstract][Full Text] [Related]
17. Opposing effects of curcuminoids on serum stimulated and unstimulated angiogenic response.
Kiran MS; Kumar VB; Viji RI; Sherin GT; Rajasekharan KN; Sudhakaran PR
J Cell Physiol; 2008 Apr; 215(1):251-64. PubMed ID: 17960570
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.
McGonigle JS; Giachelli CM; Scatena M
Angiogenesis; 2009; 12(1):35-46. PubMed ID: 19105036
[TBL] [Abstract][Full Text] [Related]
19. In vitro angiogenic effects of pancreatic bile salt-dependent lipase.
Rebaï O; Le Petit-Thevenin J; Bruneau N; Lombardo D; Vérine A
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):359-64. PubMed ID: 15569825
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
